These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 2967800
1. Use of a glycopeptide antibiotic, teicoplanin, in the treatment of septicaemia caused by gram-positive bacteria. Webster A, Wilson AP, Treasure T, Grüneberg RN. Int J Clin Pharmacol Res; 1988; 8(2):95-8. PubMed ID: 2967800 [Abstract] [Full Text] [Related]
5. Teicoplanin in the treatment of bone and joint infections. Teicoplanin Bone and Joint Cooperative Study Group, USA. LeFrock JL, Ristuccia AM, Ristuccia PA, Quenzer RW, Haggerty PG, Allen JE, Lettau LA, Schwartz R, Appleby D. Eur J Surg Suppl; 1992; (567):9-13. PubMed ID: 1381644 [Abstract] [Full Text] [Related]
9. [Teicoplanin and Gram-positive coccus infections. Results of a multicenter study on 66 cases]. Dureux JB, Canton P, Chavanet P, Chippaux C, Dupeyron JP, Estavoyer JM, Giorgi C, Jaeger A, Jehl F, Kazmierzack A. Pathol Biol (Paris); 1987 May; 35(5):511-5. PubMed ID: 2956564 [Abstract] [Full Text] [Related]
10. [Role of teicoplanin in the ambulatory treatment of infections in children due to gram-positive microorganisms]. Debbag R, Paganini H, Gómez S, Casimir L, Stamboulian D. Medicina (B Aires); 2002 May; 62 Suppl 2():48-51. PubMed ID: 12481489 [Abstract] [Full Text] [Related]
11. Spanish experience with teicoplanin. Fernández-Guerrero M, Gobernado M, Ariza J, Williams A. Scand J Infect Dis Suppl; 1990 May; 72():38-44. PubMed ID: 2151066 [Abstract] [Full Text] [Related]
12. [Staphylococcal infection in the newborn: teicoplanin therapy]. Fanos V, Khoory BJ, Danieli D, Padovani EM. Pediatr Med Chir; 1993 May; 15(6):579-82. PubMed ID: 8197017 [Abstract] [Full Text] [Related]
13. Glycopeptides in the treatment of staphylococcal infections. Daschner FD, Kropec A. Eur J Clin Microbiol Infect Dis; 1995 May; 14 Suppl 1():S12-7. PubMed ID: 7729466 [Abstract] [Full Text] [Related]
14. Efficacy of teicoplanin as antimicrobial treatment of severe nosocomial infections caused by gram-positive bacteria: a preliminary study. Micozzi A, Venditti M, Brandimarte C, Baiocchi P, Martino P, Serra P. Chemioterapia; 1988 Apr; 7(2):101-4. PubMed ID: 2969302 [Abstract] [Full Text] [Related]
15. Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections. Bibler MR, Frame PT, Hagler DN, Bode RB, Staneck JL, Thamlikitkul V, Harris JE, Haregewoin A, Bullock WE. Antimicrob Agents Chemother; 1987 Feb; 31(2):207-12. PubMed ID: 2952062 [Abstract] [Full Text] [Related]
16. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study. Huang JH, Hsu RB. Scand J Infect Dis; 2008 Feb; 40(6-7):462-7. PubMed ID: 18584532 [Abstract] [Full Text] [Related]
17. Vancomycin therapy for infective endocarditis. Geraci JE, Wilson WR. Rev Infect Dis; 1981 Feb; 3 suppl():S250-8. PubMed ID: 7342289 [Abstract] [Full Text] [Related]
18. Teicoplanin in the therapy of staphylococcal neuroshunt infections. Maserati R, Cruciani M, Azzini M, Carnevale C, Suter F, Concia E. Int J Clin Pharmacol Res; 1987 Feb; 7(3):207-13. PubMed ID: 2954919 [Abstract] [Full Text] [Related]
19. The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis. Webster A, Wilson AP, Williams AH, Treasure T, Grüneberg RN. Postgrad Med J; 1987 Aug; 63(742):621-4. PubMed ID: 2962071 [Abstract] [Full Text] [Related]
20. Immunocompromised animal models for the study of antibiotic combinations. Calandra T, Glauser MP. Am J Med; 1986 May 30; 80(5C):45-52. PubMed ID: 3087166 [Abstract] [Full Text] [Related] Page: [Next] [New Search]